Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Dystrophies”

385 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 385 results

Testing effectiveness (Phase 2)UnknownNCT02709876
What this trial is testing

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Stem Cells Arabia 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07082855
What this trial is testing

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaInherited Retinal DystrophyRetina Disorder
Zhongshan Ophthalmic Center, Sun Yat-sen University 126
Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509229
What this trial is testing

9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients

Who this might be right for
Retinitis Pigmentosa
Sheba Medical Center 41
Not applicableStudy completedNCT01835002
What this trial is testing

Transcorneal Electrical Stimulation - Multicenter Safety Study

Who this might be right for
Retinitis Pigmentosa
Okuvision GmbH 105
Testing effectiveness (Phase 2)Study completedNCT03374657
What this trial is testing

A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Novartis Pharmaceuticals 12
Not applicableNot Yet RecruitingNCT05786287
What this trial is testing

Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
PT. Prodia Stem Cell Indonesia 18
Not applicableStudy completedNCT03322930
What this trial is testing

Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis PigmentosaAMD
Retina Foundation of the Southwest 40
Early research (Phase 1)Study completedNCT01521793
What this trial is testing

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Who this might be right for
LCA (Leber Congenital Amaurosis)RP (Retinitis Pigmentosa)
QLT Inc. 27
Testing effectiveness (Phase 2)Study completedNCT02556736
What this trial is testing

AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Who this might be right for
Advanced Retinitis Pigmentosa
AbbVie 14
Not applicableStudy completedNCT02445612
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 13
Not applicableActive Not RecruitingNCT02086890
What this trial is testing

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Nova Southeastern University 21
Not applicableStudy completedNCT03597399
What this trial is testing

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Who this might be right for
Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
Spark Therapeutics, Inc. 87
Large-scale testing (Phase 3)Active Not RecruitingNCT07054632
What this trial is testing

Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations

Who this might be right for
Inherited Retinal Dystrophy Associated With RPE65 Mutations
Innostellar Biotherapeutics Co.,Ltd 30
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05203939
What this trial is testing

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Who this might be right for
Retinitis PigmentosaLeber Congenital Amaurosis
Ocugen 22
Testing effectiveness (Phase 2)Study completedNCT01461213
What this trial is testing

Gene Therapy for Blindness Caused by Choroideremia

Who this might be right for
Choroideremia
University of Oxford 14
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableUnknownNCT02860520
What this trial is testing

Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.

Who this might be right for
Retinitis Pigmentosa
University Hospital, Strasbourg, France 500
Not applicableStudy completedNCT03349242
What this trial is testing

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

Who this might be right for
Retinitis Pigmentosa
MeiraGTx UK II Ltd 140
Load More Results